X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
SHASUN PHARMA Fact Sheet, SHASUN PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA Fact Sheet   (SHSCH)

Here is the latest financial fact sheet of SHASUN PHARMA. For more details, see the SHASUN PHARMA quarterly results and SHASUN PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

SHASUN PHARMA Price History

Price Rs 428.9
Mkt Cap Rs m 25,774
Vol '000 79.8
P/E X 123.9
P/CF X 28.8
EPS (TTM) Rs 3.5
% ch % 5.5
No. of shares m 60.10
% ch week % 11.9
% ch 1-mth % 7.4
% ch 12-mth % 102.2
52 week H/L Rs 432.1/211.6
(As on Nov 17, 2015 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SHASUN PHARMA Financials

No. of Mths
Year Ending
12
Mar-10
*
12
Mar-11
*
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
5-Yr Chart
Click to enlarge
SHASUN PHARMA EQUITY SHARE DATA
High Rs541019218694 
Low Rs1249386046 
Sales per share (Unadj.) Rs158.4171.9193.5191.6214.2 
Earnings per share (Unadj.) Rs0.8-2.918.29.45.3 
Diluted earnings per shareRs0.6-2.416.78.85.0 
Cash flow per share (Unadj.) Rs8.64.825.618.715.8 
Dividends per share (Unadj.) Rs1.000.302.401.501.00 
Adj. dividends per shareRs0.800.242.201.410.94 
Dividend yield (eoy) %3.00.43.71.21.4 
Book value per share (Unadj.) Rs24.417.340.247.753.3 
Adj. book value per shareRs19.614.036.844.950.3 
Shares outstanding (eoy) m48.3148.5455.1256.6256.62 
Bonus/Rights/Conversions  -ESOPPIPI- 
Price / Sales ratio x0.20.40.30.60.3 
Avg P/E ratio x42.4-25.83.613.113.1 
P/CF ratio (eoy) x3.815.52.56.64.4 
Price / Book Value ratio x1.44.31.62.61.3 
Dividend payout %128.5-10.313.216.018.7 
Avg Mkt Cap Rs m1,5943,6413,5836,9643,958 
No. of employees `0001.5NA1.5NANA 
Total wages/salary Rs m1,4031,4321,5941,8662,164 
Avg. sales/employee Rs Th5,278.9NM7,109.3NMNM 
Avg. wages/employee Rs Th967.7NM1,062.7NMNM 
Avg. net profit/employee Rs Th25.9NM670.5NMNM 
SHASUN PHARMA INCOME DATA
Net Sales Rs m7,6548,34510,66410,84812,127 
Other income Rs m221220130183229 
Total revenues Rs m7,8758,56410,79411,03012,356 
Gross profit Rs m2927151,2301,1021,009 
Depreciation Rs m379376406527594 
Interest Rs m301323437255415 
Profit before tax Rs m-167236517504230 
Minority Interest Rs m00000 
Prior Period Items Rs m0-408000 
Extraordinary Inc (Exp) Rs m187028000 
Tax Rs m-18-30-209-26-73 
Profit after tax Rs m38-1411,006530302 
Gross profit margin %3.88.611.510.28.3 
Effective tax rate %10.5-12.8-40.5-5.2-31.7 
Net profit margin %0.5-1.79.44.92.5 
SHASUN PHARMA BALANCE SHEET DATA
Current assets Rs m3,8863,7254,7925,3126,884 
Current liabilities Rs m2,0764,7465,5456,4918,456 
Net working cap to sales %23.6-12.2-7.1-10.9-13.0 
Current ratio x1.90.80.90.80.8 
Inventory Days Days4556475762 
Debtors Days Days92697989108 
Net fixed assets Rs m2,7462,6043,3084,4564,970 
Share capital Rs m9797110113113 
"Free" reserves Rs m9077392,0822,6052,875 
Net worth Rs m1,1788392,2132,7003,020 
Long term debt Rs m3,2646727791,1831,817 
Total assets Rs m6,6356,5458,60510,44513,347 
Interest coverage x0.41.72.23.01.6 
Debt to equity ratio x2.80.80.40.40.6 
Sales to assets ratio x1.21.31.21.00.9 
Return on assets %5.12.816.87.55.4 
Return on equity %3.2-16.845.419.610.0 
Return on capital %7.210.041.219.513.3 
Exports to sales %40.646.846.747.046.4 
Imports to sales %10.813.714.413.714.2 
Exports (fob) Rs m3,1073,9024,9825,1015,622 
Imports (cif) Rs m8261,1471,5351,4841,728 
Fx inflow Rs m3,2834,0115,0835,2585,843 
Fx outflow Rs m8281,3441,7911,7072,173 
Net fx Rs m2,4542,6673,2923,5523,669 
SHASUN PHARMA CASH FLOW
From Operations Rs m 370 590 508 349 398 
From Investments Rs m 96 -321 -773 -1,611 -1,635 
From Financial Activity Rs m -398 -279 316 1,172 1,309 
Net Cashflow Rs m 68 -10 52 -90 71 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 39.2%
Foreign collaborators 0.0%
Indian inst/Mut Fund 3.6%
FIIs 17.6%
ADR/GDR 0.0%
Free float 39.6%
Shareholders 20,750
Pledged promoter(s) holding 12.3%
 

Company Information

REGD OFF Batra Centre, 3rd & 4th Floor, 28, Sardar Patel Road, Guindy, Chennai - 600 032
E-MAIL muralikrishna@shasun.com WEB www.shasun.com
TELEPHONE (044) 4344 6700 FAX (044) 2235 0278
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Integrated Enterprises, Kences Towers, Ramakrishna St., Chennai-17
AUDITOR B. S. R & Co.
CHM: R. Kannan COMP SEC: S. Murali Krishna YEAR OF INC: 1976 BSE CODE: 524552 FV (Rs): 2 DIV YIELD (%): 0.2

More Pharmaceuticals Company Fact Sheets:   SUVEN LIFE  PLETHICO PHARMA  IPCA LABS  VENUS REMEDIES  PFIZER  

Compare SHASUN PHARMA With:   SUVEN LIFE  PLETHICO PHARMA  IPCA LABS  VENUS REMEDIES  PFIZER  

Compare SHASUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Depreciating Rupee, Rising Fuel Prices, and Top Cues in Focus Today(Pre-Open)

Share markets in India closed on a negative note yesterday. Sectoral indices traded on a mixed note, with stocks in the metal sector and stocks in the oil and gas sector, leading the losses.

Views on news

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SHASUN PHARMA

SHASUN PHARMA 8-QTR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS